Abstract: A turbine engine compressor including a casing having its inside wall defining an aerodynamic reference surface for a gas-passing passage and in which a rotor wheel having radial blades is mounted. A circumferential trench is formed in the inside wall of the casing. Its shape is defined from upstream to downstream by three surfaces, respectively an upstream surface, a middle surface, and a downstream surface, which surfaces are substantially conical. The upstream surface extends upstream from the leading edges of the blades. The middle surface is substantially parallel to the aerodynamic reference surface. The downstream surface extends downstream at least as far as the trailing edges of the blades. The junction between the middle and downstream surfaces is in a range of 30% to 80% or 50% to 65% of the axial length of the blades starting from their leading edges.

Abstract: A turbine engine compressor including a casing having its inside wall defining an aerodynamic reference surface for a gas-passing passage and in which a rotor wheel having radial blades is mounted. A circumferential trench is formed in the inside wall of the casing. Its shape is defined from upstream to downstream by three surfaces, respectively an upstream surface, a middle surface, and a downstream surface, which surfaces are substantially conical. The upstream surface extends upstream from the leading edges of the blades. The middle surface is substantially parallel to the aerodynamic reference surface. The downstream surface extends downstream at least as far as the trailing edges of the blades. The junction between the middle and downstream surfaces is in a range of 30% to 80% or 50% to 65% of the axial length of the blades starting from their leading edges.

Abstract: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

Abstract: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

Abstract: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

Abstract: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

Abstract: The present invention is concerned with novel pharmaceutical compositions of itraconazole which can be administered to a mammal suffering from a fungal infection, whereby a single such dosage form can be administered once daily, and in addition at any time of the day independently of the food taken in by said mammal. These novel compositions comprise particles obtainable by melt-extruding a mixture comprising itraconazole and an appropriate water-soluble polymer and subsequently milling said melt-extruded mixture.

Abstract: A method and system for treating Hepatitis C includes using an implantable pump and an outlet catheter. A proximal end of the outlet catheter is fluidly connected to an outlet port of the pump. A distal end of the outlet catheter is sized to deliver medication from the pump to a liver of living organism, preferably a human being. By delivering medication directly to the liver the effects of the antiviral therapeutics are enhanced, and the impact of Hepatitis C infection is reduced.

Abstract: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

Abstract: The present invention is concerned with novel pharmaceutical compositions of lipid lowering agents which can be administered to a mammal suffering from hyperlipidemia, obesitas or atherosclerosis, whereby a single such dosage form can be administered once daily, and in addition at any time of the day independently of the food taken in by said mammal. These novel compositions comprise particles obtainable by melt-extruding a mixture comprising a lipid lowering agent and an appropriate water-soluble polymer and subsequently milling said melt-extruded mixture.